CCL8/MCP-2 Antibody (CCL8/3683) [DyLight 488]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-14173G
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunohistochemistry-Paraffin
Label
DyLight 488 (Excitation = 493 nm, Emission = 518 nm)
Antibody Source
Monoclonal Mouse IgG2c Kappa Clone # CCL8/3683
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for CCL8/MCP-2 Antibody (CCL8/3683) [DyLight 488]
Immunogen
Human recombinant CCL8/MCP-2 protein fragment (around aa1-99) (exact sequence is proprietary) (Uniprot: P80075)
Reactivity Notes
0
Localization
Secreted
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2c Kappa
Applications for CCL8/MCP-2 Antibody (CCL8/3683) [DyLight 488]
Application
Recommended Usage
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CCL8/MCP-2
Alternate Names
MCP-2, MCP2
Gene Symbol
CCL8
Additional CCL8/MCP-2 Products
Product Documents for CCL8/MCP-2 Antibody (CCL8/3683) [DyLight 488]
Product Specific Notices for CCL8/MCP-2 Antibody (CCL8/3683) [DyLight 488]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...